The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โABBVโ.
According to AbbVie's latest financial reports and stock price the company's current number of shares outstanding is 1,768,000,000. At the end of 2024 the company had 1,768,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.